Treatments
Approved Gene-Editing Therapies
Every gene-editing medicine that a national regulator has authorised, worldwide.
本列表的构建方式
This list is deliberately short, and its shortness is the point. Enormous scientific progress has so far produced a very small number of approved editing medicines. Everything else on this site that sounds promising is research.
| # | 词条 | 分类 | 状态 |
|---|---|---|---|
| 1 | Casgevy (exagamglogene autotemcel) The first CRISPR-based medicine approved anywhere in the world — a one-time therapy made… | Sickle cell disease; beta thalassemia | Approved |
| 2 | Lyfgenia (lovotibeglogene autotemcel) Approved on the same day as Casgevy for sickle cell disease — but a gene-addition… | Sickle cell disease | Approved |
| 3 | Zynteglo (betibeglogene autotemcel) An approved gene-addition therapy for transfusion-dependent beta thalassemia — the… | Beta thalassemia | Approved |
这份列表无法告诉你什么Approval is country-specific and does not mean a treatment is available, affordable or suitable for any individual. This list includes gene-addition therapies where they are approved for the same conditions, clearly labelled, because the distinction is the point.